Zeynep Gizem İSLAMOĞLU KAYA, Adem KUCUK, Mehmet UNAL, Fatma Tunçez AKYÜREK

Evaluation of frequency of irritable bowel syndrome in patients with chronic urticaria

Aim: Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder. Urticaria is a disease with papules and plaques accompanied by pruritus and edema. In this study, the relationship between these two diseases, which have many common features, was evaluated.Material and Methods: Patients with urticaria and volunteers who did not have any dermatologic disease were included in the study. Participants were assessed for diagnosis of IBS according to Rome III diagnostic criteria. In addition, findings supporting IBS diagnosis, and fecal shape and consistency were evaluated.Results: Fifty urticaria patients (18 males - 36% and 32 females - 64%) and 70 volunteers (38 males - 54.3% and 32 females - 45.7%) were evaluated. The mean age of the urticaria group was 34.8 ± 15.0; the mean age of the control group was 25.8 ± 10.9. IBS was detected in 34 (68%) patients in the urticaria group; and in 22 (31.4%) controls (p

PDF

___

Lillestøl K, Helgeland L, Arslan Lied G, Florvaag E, Valeur J, Lind R, et al. Indications of ‘atopic bowel’ in patients with self-reported food hypersensitivity. Aliment Pharmacol Ther 2010;31(10):1112-22.
Magen E, Chikovani T. Possible therapeutic role of IgE blockade in irritable bowel syndrome. World J Gastroenterol 2016;22(43):9451-6.
Tobin MC1, Moparty B, Farhadi A, DeMeo MT, Bansal PJ, Keshavarzian A. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol 2008;100(1): 49-53.
Tan TK, Chen AC, Lin CL, Shen TC, Li TC, Wei CC. Preschoolers with allergic diseases havean increased risk of irritable bowel syndromewhen reaching school age.J Pediatr Gastroenterol Nutr. 2017;64(1):26-30.
Jones MP, Walker MM, Ford AC, Talley NJ. The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther 2014;40(4):382-91.
Pearson JS, Niven RM, Meng J, Atarodi S, Whorwell PJ. Immunoglobulin E in irritable bowel syndrome: another target for treatment? A case report and literature review. Therap Adv Gastroenterol 2015;8(5):270-7.
Cole JA, Rothman KJ, Cabral, HJ, Zhang Y, Farraye, FA. Incidence of IBS in a cohort of people with asthma. Dig Dis Sci 2007;52(2):329-35.
Shalom G, Magen E, Babaev M, Horev A, Freud T, Ben Yakov G, et al. Chronic urticaria and irritable bowel syndrome: a cross-sectional study of 11 271 patients. Br J Dermatol 2017;14.
Kocatürk Göncü E, Aktan Ş, Atakan N, Bülbül Başkan E, Erdem T, Koca R, et al. The turkish guideline for the diagnosis and management of urticaria-2016. Turkderm - Arch Turk Dermatol Venerology 2016;50(3):82-98.
Zuberbier T, Maurer M: Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol 2007;87(3):196-205.
Zuberbier T1, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al: The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014;69(7):868-87.
Longstreth GF, Wilson A, Knight K, Wong J, Chiou CF, Barghout V, et al. Irritable bowel syndrome, health care use, and costs: a US managed care perspective. Am J Gastroenterol 2003;98(3):600-7.
Can G, Yılmaz B. Approaches in the Diagnosis and Treatment of Irritable Bowel Syndrome. Güncel Gastroenteroloji Dergisi2015;19(3):171-81.
Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10(7):712-21.